TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate ...
See accompanying notes to consolidated financial statements. View original content to download multimedia:https://www.prnewswire.com/news-releases/accelerate ...
New data shows the Accelerate Arc System enables automated and rapid sample preparation that yields robust reportability and accurate microbial identification for positive blood cultures using MALDI ...
Accelerate Diagnostics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Accelerate ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Accelerate Diagnostics has filed ...
Tucson-based Accelerate Diagnostics Inc. has launched a $45 million offering of stock-purchase rights to existing shareholders to help fund commercialization of its technology to rapidly detect and ...
A shareholder lawsuit filed in U.S. District Court targets a local biotech startup, claiming it misrepresented its proprietary technology. The lawsuit points to questions raised last year by the ...
TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results